Optimal distribution problem of COVID-19 vaccines: Russia’s experience using linear programming method

This research aims to develop and assess a mathematical model based on linear programming (LP) to optimize the distribution of COVID-19 vaccines, considering population priority groups, epidemic dynamics, and vaccine availability. We analyzed data on morbidity, mortality, and vaccine distribution in Russia using LP methods, scenario modeling, and statistical analysis. The findings of the study indicate a significant reduction in overall mortality to 5.2 per 100,000 individuals, with a vaccine effectiveness of 89% and vaccination coverage reaching 80%. The model incorporates epidemic parameters such as morbidity, mortality rates, virus spread rate, and characteristics of population groups, including age categories, healthcare and education workers, and vulnerable groups such as the elderly and those with chronic conditions. LP was applied to optimize vaccine distribution by formulating an objective function and constraints based on factors such as vaccine availability, population priorities, and epidemic dynamics, with scenario modeling used to simulate different epidemic conditions and assess the model’s stability and effectiveness. The assessment of differences using a 99.5% confidence interval and statistical significance in vaccine distribution changes yielded p < 0.001. The developed LP model effectively optimized vaccine distribution, reducing overall mortality and ensuring vaccination efficiency. The results were adapted to various epidemic scenarios and successfully correlated with real-world data obtained from official statistical reports of the Ministry of Health of the Russian Federation, regional epidemiological centers (including the Moscow Center), and vaccine manufacturers. The data covered the period from January 2021 to December 2022. To achieve a substantial impact of vaccines, it is essential to reach a population coverage of 60-70%.

Authors

Institutions

Publication Details

Journal
Electronic Journal of General Medicine
Published
2025-05-14
DOI
https://doi.org/10.29333/ejgm/16367
Primary Topic
COVID-19 epidemiological studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Optimal distribution problem of COVID-19 vaccines: Russia’s experience using linear programming method

Zakharova K.E., Taisiya Aysina, Dmitriy Ermakov, Oxana Kartashova et al.
Electronic Journal of General Medicine
COVID-19 epidemiological studies
article

Optimal distribution problem of COVID-19 vaccines: Russia’s experience using linear programming method

Zakharova K.E., Taisiya Aysina, Dmitriy Ermakov, Oxana Kartashova, Iza Berechikidze
article en

Abstract

This research aims to develop and assess a mathematical model based on linear programming (LP) to optimize the distribution of COVID-19 vaccines, considering population priority groups, epidemic dynamics, and vaccine availability. We analyzed data on morbidity, mortality, and vaccine distribution in Russia using LP methods, scenario modeling, and statistical analysis. The findings of the study indicate a significant reduction in overall mortality to 5.2 per 100,000 individuals, with a vaccine effectiveness of 89% and vaccination coverage reaching 80%. The model incorporates epidemic parameters such as morbidity, mortality rates, virus spread rate, and characteristics of population groups, including age categories, healthcare and education workers, and vulnerable groups such as the elderly and those with chronic conditions. LP was applied to optimize vaccine distribution by formulating an objective function and constraints based on factors such as vaccine availability, population priorities, and epidemic dynamics, with scenario modeling used to simulate different epidemic conditions and assess the model’s stability and effectiveness. The assessment of differences using a 99.5% confidence interval and statistical significance in vaccine distribution changes yielded p < 0.001. The developed LP model effectively optimized vaccine distribution, reducing overall mortality and ensuring vaccination efficiency. The results were adapted to various epidemic scenarios and successfully correlated with real-world data obtained from official statistical reports of the Ministry of Health of the Russian Federation, regional epidemiological centers (including the Moscow Center), and vaccine manufacturers. The data covered the period from January 2021 to December 2022. To achieve a substantial impact of vaccines, it is essential to reach a population coverage of 60-70%.

Electronic Journal of General MedicineVol. 22(4)
Sechenov University (RU)
Openalex Percentile: Top 88%
COVID-19 epidemiological studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.